#110 – Lew Cantley, Ph.D.: Cancer metabolism, cancer therapies, and the discovery of PI3K

ℹ️ EPISODE INFO

Released

July 8, 2020

Duration

2h 11m

Channel

Peter Attia MD

Watch on YouTube

▶ Open ↗

📝 EPISODE DESCRIPTION

Sign up to receive Peter's email newsletter: https://bit.ly/4c602k2 Original release date: 5/11/20 In this episode, Lew Cantley, Professor of cancer biology and Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College in NYC, walks us through his amazing discovery of phosphoinositide 3-kinase (PI3K) and the implications for the care of patients with cancer. He explains various combinations of therapies being tested and used, including the possibility of pairing prescriptive nutritional therapies to increase the efficacy of drugs like PI3K inhibitors. Lew also explains the metabolic nature of cancer through the lens of his research into the connection between sugar consumption, insulin resistance, and tumor growth. Additionally, Lew provides some details about his exciting new clinical trial that is just now enrolling patients with stage 4 breast cancer and endometrial cancer. We discuss: -Teaching science through the lens of discovery—a better approach to learning science [5:15]; -The metabolic nature of cancer, mitochondria, and a more nuanced explanation of the Warburg Effect [8:30]; -The observation that convinced Lew to stop eating sugar [20:15]; -The connection between obesity, insulin resistance, and cancer [25:30]; -Sugar consumption and tumor growth—What did Lew’s 2019 paper find? [32:00]; -Natural sugar vs. HFCS, fruit vs. fruit juice, insulin response and cancer growth [43:00]; -Increasing efficacy of PI3K inhibitors with ketogenic diets, SGLT2 inhibitors, and metformin [53:30]; -Lew’s clinical trial enrolling stage 4 breast cancer and endometrial cancer patients [1:07:30]; -Pairing diet with drug could be the future of cancer treatment [1:09:30]; -PI3K inhibitors on the market, alpha vs. delta isoform, and the possibility of pairing them with a food prescription [1:16:15]; -What questions will Lew be focused on in the next chapter of his career? [1:22:15]; -Lew’s early work that ultimately led to the discovery of PI3K [1:27:30]; -Studying the mechanism by which mitochondria make ATP [1:30:45]; -How understanding the mechanism by which insulin drove glucose uptake into a cell got Lew closer to finding PI3K [1:38:15]; -How Lew knew PI3K was important in driving growth of cancer cells [1:55:00]; -Lew’s unlikely observation of phosphorylation at the 3′ position of the inositol ring resulting in the formation of phosphatidylinositol-3-phosphate [1:59:00]; and -More. Show notes page: https://peterattiamd.com/lewcantley/ -------- About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle

🎤 SPEAKERS

• Peter Attia

  host

  Physician and host of The Drive podcast, known for long-form interviews on medicine and health science.

• Lew Cantley

  guest

  Cancer biologist and biochemist known for the discovery of PI3K and research on cancer metabolism and signaling.

🧾 EPISODE SUMMARY

In this episode of Peter Attia MD, featuring Peter Attia and Lew Cantley, #110 – Lew Cantley, Ph.D.: Cancer metabolism, cancer therapies, and the discovery of PI3K explores lew Cantley on Insulin, Sugar, PI3K Inhibitors, and Cancer Metabolism Cantley describes how insulin activates PI3K, the same enzyme many oncogenes use, which led him to conclude that insulin resistance and high insulin accelerate tumor growth.

🔗 RELATED EPISODES

409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles

#117 – Stanley Perlman, M.D., Ph.D.: Insights from a coronavirus expert on COVID-19

#150-Senator Bill Frist, MD: A modern Renaissance man's journey through science, politics & business

#130 - Carol Tavris, Ph.D. & Elliot Aronson, Ph.D.: Recognizing and overcoming cognitive dissonance

#96–David Epstein: How range of experience leads to better performance in a highly specialized world

#125 - John Arnold: The most prolific philanthropist you may not have heard of